Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2012
06/14/2012WO2012075533A1 Multifunctional nanoparticles
06/14/2012WO2012053741A3 Nucleic acid molecules inducing rna interference, and uses thereof
06/14/2012WO2012051571A3 Nucleic acid modulators of clec-2
06/14/2012WO2012047679A3 Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria
06/14/2012WO2012047099A3 Method for extracting dna from nematodes and plant cells
06/14/2012WO2012035050A3 Factor viii variants having a decreased cellular uptake
06/14/2012WO2012034023A3 Recombinant clostridia that fix co2 and co and uses thereof
06/14/2012WO2012033875A3 Compositions and methods for nucleic acid based diagnostic assays for variable sequence targets
06/14/2012WO2012033324A3 Novel biological detection method for dioxins in serum, and a diagnostic use therefor in metabolic syndrome and related conditions
06/14/2012WO2012031207A3 Methods and compositions for correlating genetic markers with prostate cancer risk
06/14/2012WO2012030956A3 Mirna detection of pancreatic cancer
06/14/2012WO2012030840A9 Gene signatures for cancer diagnosis and prognosis
06/14/2012WO2012030136A3 Oligonucleotides for detecting listeria spp. and use thereof
06/14/2012WO2012012676A3 Use of mir-29 for cell protection
06/14/2012WO2012007945A3 Isolated polynucleotides and methods and plants using same for regulating plant acidity
06/14/2012WO2012006243A3 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
06/14/2012WO2012002775A4 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
06/14/2012WO2011163531A3 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
06/14/2012WO2011153235A3 Compositions featuring superoxide dismutase polypeptides having enhanced anti-oxidant activity
06/14/2012WO2011149310A9 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
06/14/2012WO2011149267A9 Primer set for selecting pmmov-resistant pepper varieties, method thereof, and kit thereof
06/14/2012WO2011139385A3 Genetic signatures in hiv-1 subtype c envelope glycoproteins
06/14/2012WO2011132890A9 Transformant for enhancing bioethanol production, and method for producing ethanol by using said strain
06/14/2012WO2011056060A8 Recombinant matrix protein of nipah virus
06/14/2012WO2011027129A9 Treatment of vasculoproliferative conditions
06/14/2012US20120151633 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/14/2012US20120151630 Methods and materials for making and using transgenic dicamba-degrading organisms
06/14/2012US20120151629 Nematode-Resistant Transgenic Plants
06/14/2012US20120151628 Generation of plants with altered protein, fiber, or oil content
06/14/2012US20120151627 Selectable marker gene and methods of use thereof in transplastomic plants
06/14/2012US20120151626 Method for excision of plant embryos for transformation
06/14/2012US20120151624 Garden bean cultivar h28121
06/14/2012US20120151623 Lettuce cultivar keeper
06/14/2012US20120151621 Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants
06/14/2012US20120151620 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
06/14/2012US20120151618 Pepper hybrid ps09956434
06/14/2012US20120151617 Pepper hybrid ps09967422
06/14/2012US20120151616 Pepper hybrid ps09954859
06/14/2012US20120151615 Pepper hybrid ps09943431
06/14/2012US20120151614 Vector utilizing borna disease virus and use thereof
06/14/2012US20120151613 Mutants of activation-induced cytidine deaminase (aid) and methods of use
06/14/2012US20120151610 Soluble "heavy-chain only" antibodies
06/14/2012US20120149892 Nucleic Acid Molecules Encoding Antibodies That Bind Cell-Associated CA 125/O772P
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149880 Nucleic Acid Cassette For Producing Recombinant Antibodies
06/14/2012US20120149874 Method for preparing recombinant glycoproteins with high sialic acid content
06/14/2012US20120149764 Aptamers that bind thrombin with high affinity
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149754 Methods for modulating the expression and aggregation of cag-expanded gene product in cells and methods for identifying agents useful for doing the same
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120149631 Antimicrobial and antibiofilm activity of cathelicidins
06/14/2012US20120149624 Subtilase Variants
06/14/2012US20120149597 Protein fragment complementation assays for high-throughput and high-content screening
06/14/2012US20120149591 In vitro peptide expression library
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149119 Nucleic acid based fluorescent sensor for mercury detection
06/14/2012US20120149116 Cellulose degradable yeast and method for production thereof
06/14/2012US20120149115 Targeted genomic rearrangements using site-specific nucleases
06/14/2012US20120149109 Modulation of transthyretin expression
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149101 Methods and kits for regulating intracellular trafficking of a target protein
06/14/2012US20120149097 Nonviral vectors for delivering polynucleotides to target tissue
06/14/2012US20120149096 Prrs viruses, infectious clones, mutants thereof, and method of use
06/14/2012US20120149095 Dna promoters and anthrax vaccines
06/14/2012US20120149087 Glucoamylase variants with altered properties
06/14/2012US20120149084 Fusion proteins
06/14/2012US20120149078 Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same
06/14/2012US20120149077 Mesophilic and Thermophilic Organisms Modified to Produce Acrylate, and Methods of Use Thereof
06/14/2012US20120149073 Ketoreductase Polypeptides for the Preparation of Phenylephrine
06/14/2012US20120149071 D-aminoacylase
06/14/2012US20120149070 Variants of glucoamylase
06/14/2012US20120149069 Methods and compositions for seamless cloning of nucleic acid molecules
06/14/2012US20120149068 Methods and compositions for amplification of rna sequences
06/14/2012US20120149067 Methods for producing hyaluronan in a recombinant host cell
06/14/2012US20120149065 Use of manganese peroxidase for enzymatic hydrolysis of lignocellulosic material
06/14/2012US20120149060 Nucleic Acids for Cloning and Expressing Multiprotein Complexes
06/14/2012US20120149053 Carrier peptide fragment and use thereof
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120149028 Detection and visualization of the cell cycle in living cells
06/14/2012US20120149025 Screening Methods for Human Embryonic Stem Cells
06/14/2012US20120149024 Cotton event mon 88913 and compositions and methods for detection thereof
06/14/2012US20120149010 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
06/14/2012US20120148706 Novel protein having b-glucosidase activity and uses thereof
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148624 Mutants of cholesterol-dependent cytolysins and uses thereof
06/14/2012US20120148622 Live Attenuated Influenza Virus Vaccines Comprising Microrna Response Elements
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148612 Grass peptides for vaccine
06/14/2012US20120148607 Anti c-met antibodies
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148601 Bacterial superantigen vaccines
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148597 Human monoclonal antibodies to ctla-4
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies